Literature DB >> 22154319

Parental intermittent claudication as risk factor for claudication in adults.

Scott G Prushik1, Alik Farber, Philimon Gona, Peter Shrader, Michael J Pencina, Ralph B D'Agostino, Joanne M Murabito.   

Abstract

Little is known about the familial aggregation of intermittent claudication (IC). Our objective was to examine whether parental IC increased the risk of IC in adult offspring, independent of the established cardiovascular risk factors. We evaluated the Offspring Cohort Participants of the Framingham Heart Study who were ≥30 years old, cardiovascular disease free, and had both parents enrolled in the Framingham Heart Study (n = 2,970 unique participants, 53% women). Pooled proportional hazards regression analysis was used to examine whether the 12-year risk of incident IC in offspring participants was associated with parental IC, adjusting for age, gender, diabetes, smoking, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, and antihypertensive and lipid treatment. Of the 909 person-examinations in the parental IC history group and 5,397 person-examinations in the no-parental IC history group, there were 101 incident IC events (29 with parental IC history and 72 without a parental IC history) during follow-up. The age- and gender-adjusted 12-year cumulative incidence rate per 1,000 person-years was 5.08 (95% confidence interval [CI] 2.74 to 7.33) and 2.34 (95% CI 1.46 to 3.19) in participants with and without a parental IC history. A parental history of IC significantly increased the risk of incident IC in the offspring (multivariable adjusted hazard ratio 1.81, 95% CI 1.14 to 2.88). The hazard ratio was unchanged, with an adjustment for the occurrence of cardiovascular disease (hazard ratio 1.83, 95% CI 1.15 to 2.91). In conclusion, IC in parents increases the risk of IC in adult offspring, independent of the established risk factors. These data suggest a genetic component of peripheral artery disease and support future research into genetic causes. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22154319      PMCID: PMC3288128          DOI: 10.1016/j.amjcard.2011.10.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey.

Authors:  Alan T Hirsch; Timothy P Murphy; Marge B Lovell; Gwen Twillman; Diane Treat-Jacobson; Eileen M Harwood; Emile R Mohler; Mark A Creager; Robert W Hobson; Rose Marie Robertson; W James Howard; Paul Schroeder; Michael H Criqui
Journal:  Circulation       Date:  2007-09-17       Impact factor: 29.690

2.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

Review 3.  Family study designs in the age of genome-wide association studies: experience from the Framingham Heart Study.

Authors:  L Adrienne Cupples
Journal:  Curr Opin Lipidol       Date:  2008-04       Impact factor: 4.776

4.  Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion.

Authors:  Andrew R Thompson; Jonathan Golledge; Jackie A Cooper; Hany Hafez; Paul E Norman; Steve E Humphries
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

5.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia.

Authors:  Ayotunde O Dokun; Sehoon Keum; Surovi Hazarika; Yongjun Li; Gregory M Lamonte; Ferrin Wheeler; Douglas A Marchuk; Brian H Annex
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

7.  Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease.

Authors:  Heribert Schunkert; Anika Götz; Peter Braund; Ralph McGinnis; David-Alexandre Tregouet; Massimo Mangino; Patrick Linsel-Nitschke; Francois Cambien; Christian Hengstenberg; Klaus Stark; Stefan Blankenberg; Laurence Tiret; Pierre Ducimetiere; Andrew Keniry; Mohammed J R Ghori; Stefan Schreiber; Nour Eddine El Mokhtari; Alistair S Hall; Richard J Dixon; Alison H Goodall; Henrike Liptau; Helen Pollard; Daniel F Schwarz; Ludwig A Hothorn; H-Erich Wichmann; Inke R König; Marcus Fischer; Christa Meisinger; Willem Ouwehand; Panos Deloukas; John R Thompson; Jeanette Erdmann; Andreas Ziegler; Nilesh J Samani
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

8.  Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke.

Authors:  Andreas Gschwendtner; Steve Bevan; John W Cole; Anna Plourde; Mar Matarin; Helen Ross-Adams; Thomas Meitinger; Erich Wichmann; Braxton D Mitchell; Karen Furie; Agnieszka Slowik; Stephen S Rich; Paul D Syme; Mary J MacLeod; James F Meschia; Jonathan Rosand; Steve J Kittner; Hugh S Markus; Bertram Müller-Myhsok; Martin Dichgans
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

9.  Association of genetic variation on chromosome 9p21.3 and arterial stiffness.

Authors:  H M Björck; T Länne; U Alehagen; K Persson; L Rundkvist; A Hamsten; U Dahlström; P Eriksson
Journal:  J Intern Med       Date:  2008-10-25       Impact factor: 8.989

10.  Peripheral arterial occlusive disease: global gene expression analyses suggest a major role for immune and inflammatory responses.

Authors:  Shijun Fu; Haiguang Zhao; Jiantao Shi; Arhat Abzhanov; Keith Crawford; Lucila Ohno-Machado; Jianqin Zhou; Yanzhi Du; Winston Patrick Kuo; Ji Zhang; Mier Jiang; Jason Gang Jin
Journal:  BMC Genomics       Date:  2008-08-01       Impact factor: 3.969

View more
  3 in total

1.  Invited Commentary: The Framingham Offspring Study-A Pioneering Investigation Into Familial Aggregation of Cardiovascular Risk.

Authors:  JoAnn E Manson; Shari S Bassuk
Journal:  Am J Epidemiol       Date:  2017-06-01       Impact factor: 4.897

2.  Change in dietary intake of adults with intermittent claudication undergoing a supervised exercise program and compared to matched controls.

Authors:  Christopher L Delaney; Michelle D Miller; Kacie M Dickinson; J Ian Spark
Journal:  Nutr J       Date:  2014-10-15       Impact factor: 3.271

3.  Screening of peripheral arterial disease in primary health care.

Authors:  Zsombor Tóth-Vajna; Gergely Tóth-Vajna; Zsuzsanna Gombos; Brigitta Szilágyi; Zoltán Járai; Márton Berczeli; Péter Sótonyi
Journal:  Vasc Health Risk Manag       Date:  2019-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.